Literature DB >> 27053009

Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise.

Daisy Motta-Santos1,2, Robson Augusto Souza Dos Santos1,2, Marilene Oliveira1,2, Fatimunnisa Qadri3, Marko Poglitsch4, Valentina Mosienko3,5, Lenice Kappes Becker6, Maria Jose Campagnole-Santos1,2, Joseph M Penninger7, Natalia Alenina1,3, Michael Bader1,3,8,9.   

Abstract

The renin-angiotensin system (RAS) is related to physiological adaptations induced by exercise. Angiotensin-converting enzyme (ACE) 2 is a major regulator of the RAS in tissues, as it metabolizes angiotensin (Ang) II to Ang-(1-7). The aim of this study was to determine the effects of ACE2 deficiency on physical performance and physiological adaptations induced by voluntary running. Physical performance, body composition and plasma angiotensin levels, as well as tissue morphology and gene expression of RAS components in the left ventricle (LV) and skeletal muscle (gastrocnemius), were evaluated in ACE2-deficient (ACE2(-/y)) and wild-type (ACE2(+/y)) mice after 6 weeks of voluntary wheel running. ACE2(-/y) mice run less than ACE2(+/y) mice (19±4.7 vs. 26±12.6 revolutions per day × 100, P<0.01). The ACE2(+/y) group presented a lower fat mass (15±1.1%) and higher muscle mass (76.6±1.6%) after 6 weeks of voluntary running compared with the sedentary control group (fat mass: 18.3±2.1%; muscle mass: 72.7±2.2). However, no change in body composition was observed in ACE2(-/y) mice after exercise. Heart and skeletal muscle hypertrophy was observed only in trained ACE2(+/y) mice. Besides a small decrease in Ang I in ACE2(-/y) mice, plasma levels of angiotensin peptides remained unchanged by exercise or ACE2 deficiency. In the LV of trained animals, AT2 gene expression was higher in ACE2(+/y) compared with ACE2(-/y) mice. ACE2 deficiency leads to an increase in AT1 gene expression in skeletal muscle. ACE expression in soleus was increased in all exercised groups. ACE2 deficiency affects physical performance and impairs cardiac and skeletal muscle adaptations to exercise.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27053009     DOI: 10.1038/hr.2016.28

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  36 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice.

Authors:  Gislaine G Guimarães; Sérgio H S Santos; Marilene L Oliveira; Elizabeth P Pimenta-Velloso; Daisy F Motta; Almir S Martins; Natalia Alenina; Michael Bader; Robson A S Santos; Maria Jose Campagnole-Santos
Journal:  Peptides       Date:  2012-08-18       Impact factor: 3.750

Review 3.  Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.

Authors:  Rasna Sabharwal; Mark W Chapleau
Journal:  Exp Physiol       Date:  2013-12-13       Impact factor: 2.969

Review 4.  The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives.

Authors:  Theodore Garland; Heidi Schutz; Mark A Chappell; Brooke K Keeney; Thomas H Meek; Lynn E Copes; Wendy Acosta; Clemens Drenowatz; Robert C Maciel; Gertjan van Dijk; Catherine M Kotz; Joey C Eisenmann
Journal:  J Exp Biol       Date:  2011-01-15       Impact factor: 3.312

5.  Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction.

Authors:  Manish S Bharadwaj; William B Strawn; Leanne Groban; Liliya M Yamaleyeva; Mark C Chappell; Carina Horta; Katie Atkins; Luciana Firmes; Susan B Gurley; K Bridget Brosnihan
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

6.  The aromatic amino acid tryptophan stimulates skeletal muscle IGF1/p70s6k/mTor signaling in vivo and the expression of myogenic genes in vitro.

Authors:  Amy Dukes; Colleen Davis; Mona El Refaey; Sunil Upadhyay; Sarah Mork; Phonepasong Arounleut; Maribeth H Johnson; William D Hill; Carlos M Isales; Mark W Hamrick
Journal:  Nutrition       Date:  2015-03-17       Impact factor: 4.008

7.  Expression of the Mas receptor is upregulated in skeletal muscle wasting.

Authors:  María Gabriela Morales; Johanna Abrigo; Carla Meneses; Franco Cisternas; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Histochem Cell Biol       Date:  2014-09-11       Impact factor: 4.304

8.  An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana P Costa-Fraga; Frederico B De Sousa; Natalia Alenina; Michael Bader; Ruben D Sinisterra; Robson A S Santos
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.

Authors:  María Gabriela Morales; Johanna Abrigo; María José Acuña; Robson A Santos; Michael Bader; Enrique Brandan; Felipe Simon; Hugo Olguin; Daniel Cabrera; Claudio Cabello-Verrugio
Journal:  Dis Model Mech       Date:  2016-02-05       Impact factor: 5.758

10.  ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

Authors:  Cecilia Riquelme; María José Acuña; Javiera Torrejón; Daniela Rebolledo; Daniel Cabrera; Robson A Santos; Enrique Brandan
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more
  19 in total

Review 1.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

2.  Intrinsic Exercise Capacity Affects Glycine and Angiotensin-Converting Enzyme 2 (ACE2) Levels in Sedentary and Exercise Trained Rats.

Authors:  Nora Klöting; Michael Schwarzer; Estelle Heyne; Uta Ceglarek; Anne Hoffmann; Knut Krohn; Torsten Doenst; Matthias Blüher
Journal:  Metabolites       Date:  2022-06-15

3.  Blood flow restriction exercise stimulates mobilization of hematopoietic stem/progenitor cells and increases the circulating ACE2 levels in healthy adults.

Authors:  Shrinidh Joshi; Sean Mahoney; Jesmin Jahan; Logan Pitts; Kyle J Hackney; Yagna Pr Jarajapu
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

Review 4.  Pain during and after coronavirus disease 2019: Chinese perspectives.

Authors:  Feng Jiang; Wan-Li Yang; Jia-Wei Wang; Zhen Zhu; Ceng Luo; Lars Arendt-Nielsen; Xue-Jun Song
Journal:  Pain Rep       Date:  2021-05-10

5.  Angiotensin-(1-7) oral formulation improves physical performance in mountain bike athletes: a double-blinded crossover study.

Authors:  Samara Silva de Moura; Adália Táci Pereira Mendes; Francisco de Assis Dias Martins-Júnior; Nádia Lúcia Totou; Daniel Barbosa Coelho; Emerson Cruz de Oliveira; Daisy Motta-Santos; Robson Augusto Souza Dos Santos; Lenice Kappes Becker
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-05-06

6.  Physical activity: Benefits and challenges during the COVID-19 pandemic.

Authors:  Michael John Dwyer; Margherita Pasini; Stefano De Dominicis; Elda Righi
Journal:  Scand J Med Sci Sports       Date:  2020-07       Impact factor: 4.221

7.  Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response.

Authors:  Friederike Klempin; Valentina Mosienko; Susann Matthes; Daniel C Villela; Mihail Todiras; Josef M Penninger; Michael Bader; Robson A S Santos; Natalia Alenina
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

Review 8.  ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.

Authors:  Natalia Alenina; Michael Bader
Journal:  Neurochem Res       Date:  2018-11-15       Impact factor: 3.996

9.  Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Carlos M Zapata Martín Del Campo; Shaniah Pereida; Steve Maurer; Jose Campo Maldonado; Zisis Kozlakidis
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

10.  Angiotensin-(1-7) and Obesity: Role in Cardiorespiratory Fitness and COVID-19 Implications.

Authors:  Daisy Motta-Santos; Robson A S Santos; Sérgio Henrique Sousa Santos
Journal:  Obesity (Silver Spring)       Date:  2020-09-01       Impact factor: 9.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.